Astrocyte–neuron interplay in maladaptive plasticity
暂无分享,去创建一个
[1] G. Somjen. Nervenkitt: Notes on the history of the concept of neuroglia , 1988, Glia.
[2] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[3] G. I. Hatton,et al. Incidence of neuronal coupling in supraoptic nuclei of virgin and lactating rats: estimation by neurobiotin and Lucifer yellow , 1994, Brain Research.
[4] Harry T. Orr,et al. Identification and characterization of the gene causing type 1 spinocerebellar ataxia , 1994, Nature Genetics.
[5] S. Miyata,et al. Not only osmotic stress but also repeated restraint stress causes structural plasticity in the supraoptic nucleus of the rat hypothalamus , 1994, Brain Research Bulletin.
[6] SCA1 transgenic mice: a model for neurodegeneration caused by CAG trinucleotide expansion. , 1995 .
[7] M. Dragunow,et al. Neurochemical and morphological changes associated with human epilepsy , 1995, Brain Research Reviews.
[8] D. Schiffer,et al. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis , 1996, Journal of the Neurological Sciences.
[9] S. W. Davies,et al. Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.
[10] E. Freye. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1 , 1997 .
[11] Masahiko Watanabe,et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. , 1997, Science.
[12] W. Griffin,et al. Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression , 1998, Brain pathology.
[13] A. Salm,et al. Dehydration and rehydration selectively and reversibly alter glial fibrillary acidic protein immunoreactivity in the rat supraoptic nucleus and subjacent glial limitans , 1998, Glia.
[14] S. Barger,et al. S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. , 1998, Journal of neurochemistry.
[15] S. Barger,et al. S100β Increases Levels of β‐Amyloid Precursor Protein and Its Encoding mRNA in Rat Neuronal Cultures , 1998 .
[16] C. Naus,et al. Connexins regulate calcium signaling by controlling ATP release. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Dermietzel,et al. Gap junction wiring: a `new' principle in cell-to-cell communication in the nervous system? 1 Published on the World Wide Web on 4 November 1997. 1 , 1998, Brain Research Reviews.
[18] R. Dringen,et al. Synthesis of the Antioxidant Glutathione in Neurons: Supply by Astrocytes of CysGly as Precursor for Neuronal Glutathione , 1999, The Journal of Neuroscience.
[19] Shuxian Hu,et al. Gp-41-Mediated Astrocyte Inducible Nitric Oxide Synthase mRNA Expression: Involvement of Interleukin-1β Production by Microglia , 1999, The Journal of Neuroscience.
[20] G. Siegel,et al. Neurotrophic factors in Alzheimer’s and Parkinson’s disease brain , 2000, Brain Research Reviews.
[21] M M Haglund,et al. Intraoperative hippocampal electrocorticography to predict the extent of hippocampal resection in temporal lobe epilepsy surgery. , 2000, Journal of neurosurgery.
[22] G. Mora,et al. Circulating levels of tumour necrosis factor-α and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis , 2000, Neuroscience Letters.
[23] H. Sontheimer,et al. Changes in ion channel expression accompany cell cycle progression of spinal cord astrocytes , 2000, Glia.
[24] J. Thome,et al. cAMP Response Element-Mediated Gene Transcription Is Upregulated by Chronic Antidepressant Treatment , 2000, The Journal of Neuroscience.
[25] A. Salm. Mechanisms of glial retraction in the hypothalamo‐neurohypophysial system of the rat , 2000, Experimental physiology.
[26] A. Pramatarova,et al. Neuron-Specific Expression of Mutant Superoxide Dismutase 1 in Transgenic Mice Does Not Lead to Motor Impairment , 2001, The Journal of Neuroscience.
[27] A. Hunter,et al. White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat , 2001, Brain Research.
[28] J. García-Verdugo,et al. Astrocytes Give Rise to New Neurons in the Adult Mammalian Hippocampus , 2001, The Journal of Neuroscience.
[29] R. Mrak,et al. Interleukin-1, neuroinflammation, and Alzheimer’s disease , 2001, Neurobiology of Aging.
[30] N. Berman,et al. Atrial Natriuretic Peptide-like Immunoreactivity in Neurons and Astrocytes of Human Cerebellum and Inferior Olivary Complex , 2001, Journal of Histochemistry and Cytochemistry.
[31] B. Barres,et al. Control of synapse number by glia. , 2001, Science.
[32] Marc Montminy,et al. Transcriptional regulation by the phosphorylation-dependent factor CREB , 2001, Nature Reviews Molecular Cell Biology.
[33] G. Kollias,et al. CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity , 2001, Nature Neuroscience.
[34] E. Peskind,et al. Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease , 2001, Neurochemistry International.
[35] J. Hirrlinger,et al. Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones , 2002, Journal of neurochemistry.
[36] A. Heslegrave,et al. Nitric oxide‐dependent damage to neuronal mitochondria involves the NMDA receptor , 2002, The European journal of neuroscience.
[37] J. Rothstein,et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[38] V. Meininger,et al. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients , 2002, Journal of the Neurological Sciences.
[39] Wade Morishita,et al. Control of Synaptic Strength by Glial TNFα , 2002, Science.
[40] R. Malenka,et al. Control of synaptic strength by glial TNFalpha. , 2002, Science.
[41] B. Kanner,et al. The dual-function glutamate transporters: structure and molecular characterisation of the substrate-binding sites. , 2002, Biochimica et biophysica acta.
[42] Guy C. Brown,et al. Nitric oxide induces rapid, calcium‐dependent release of vesicular glutamate and ATP from cultured rat astrocytes , 2002, Glia.
[43] Thomas J Deerinck,et al. Multicolor and Electron Microscopic Imaging of Connexin Trafficking , 2002, Science.
[44] R. Ferrante,et al. Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[45] M. Matteoli,et al. Storage and Release of ATP from Astrocytes in Culture* , 2003, The Journal of Biological Chemistry.
[46] Vincenzo Bonifati,et al. Early‐onset Parkinson's disease caused by a compound heterozygous DJ‐1 mutation , 2003, Annals of neurology.
[47] David I. Smith,et al. MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons. , 2003, Journal of molecular neuroscience : MN.
[48] S. Maier,et al. GLIA: A novel drug discovery target for clinical pain , 2003, Nature Reviews Drug Discovery.
[49] M. Hediger,et al. The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects , 2004, Pflügers Archiv.
[50] Y. Kan,et al. Identification of the NF-E2-related Factor-2-dependent Genes Conferring Protection against Oxidative Stress in Primary Cortical Astrocytes Using Oligonucleotide Microarray Analysis* , 2003, The Journal of Biological Chemistry.
[51] J. Mao,et al. Altered Expression and Uptake Activity of Spinal Glutamate Transporters after Nerve Injury Contribute to the Pathogenesis of Neuropathic Pain in Rats , 2003, The Journal of Neuroscience.
[52] C. Ferrari,et al. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease , 2003, The European journal of neuroscience.
[53] E. Welker,et al. Glial Glutamate Transporters Mediate a Functional Metabolic Crosstalk between Neurons and Astrocytes in the Mouse Developing Cortex , 2003, Neuron.
[54] J. Fritschy,et al. Overexpression of Adenosine Kinase in Epileptic Hippocampus Contributes to Epileptogenesis , 2022 .
[55] L. Barbeito,et al. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis , 2004, Brain Research Reviews.
[56] J. García-Verdugo,et al. Cell types, lineage, and architecture of the germinal zone in the adult dentate gyrus , 2004, The Journal of comparative neurology.
[57] Vladimir Parpura,et al. C(a2+)-dependent glutamate release involves two classes of endoplasmic reticulum Ca(2+) stores in astrocytes. , 2004, Journal of neuroscience research.
[58] V. Fiano,et al. Astrogliosis in ALS: possible interpretations according to pathogenetic hypotheses , 2004, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[59] R. Mrak,et al. Microglia and neuroinflammation: a pathological perspective , 2004 .
[60] R. Ji,et al. Cell Signaling and the Genesis of Neuropathic Pain , 2004, Science's STKE.
[61] L. Barbeito,et al. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis , 2004, Journal of neurochemistry.
[62] Vladimir Parpura,et al. Ca2+‐dependent glutamate release involves two classes of endoplasmic reticulum Ca2+ stores in astrocytes , 2004 .
[63] E. Nagelhus,et al. Aquaporin-4 in the central nervous system: Cellular and subcellular distribution and coexpression with KIR4.1 , 2004, Neuroscience.
[64] H. Kettenmann,et al. Localization of SNARE proteins and secretory organelle proteins in astrocytes in vitro and in situ , 2004, Neuroscience Research.
[65] B. Sperner-Unterweger. Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. , 2005, Drugs.
[66] T. Takano,et al. An astrocytic basis of epilepsy , 2005, Nature Medicine.
[67] John H Krystal,et al. Extracellular metabolites in the cortex and hippocampus of epileptic patients , 2005, Annals of neurology.
[68] Steven G Potkin,et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease , 2005, Nature Medicine.
[69] G. Raivich. Like cops on the beat: the active role of resting microglia , 2005, Trends in Neurosciences.
[70] J. Romero,et al. Functional neuroanatomy of the endocannabinoid system , 2005, Pharmacology Biochemistry and Behavior.
[71] M. L. de Ceballos,et al. Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation , 2005, The Journal of Neuroscience.
[72] Shuxian Hu,et al. Synthetic cannabinoid WIN55,212‐2 inhibits generation of inflammatory mediators by IL‐1β‐stimulated human astrocytes , 2005, Glia.
[73] J. C. Greene,et al. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[74] J. Hell,et al. Thrombospondins Are Astrocyte-Secreted Proteins that Promote CNS Synaptogenesis , 2005, Cell.
[75] P. Fisher,et al. β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression , 2005, Nature.
[76] J. Meldolesi,et al. Astrocytes, from brain glue to communication elements: the revolution continues , 2005, Nature Reviews Neuroscience.
[77] L. Goldstein,et al. Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways. , 2005, Archives of neurology.
[78] M. Höltje,et al. Effects of brain‐derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development , 2005, Journal of neurochemistry.
[79] R. Caudle,et al. Memory in astrocytes: a hypothesis , 2006, Theoretical Biology and Medical Modelling.
[80] D. Boison. Adenosine and Epilepsy: From Therapeutic Rationale to New Therapeutic Strategies , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[81] V. Golovina. Visualization of localized store‐operated calcium entry in mouse astrocytes. Close proximity to the endoplasmic reticulum , 2005, The Journal of physiology.
[82] J. Feldon,et al. The International Society for Developmental Psychobiology Annual Meeting Symposium: Impact of Early Life Experiences on Brain and Behavioral Development , 2022 .
[83] L. V. Van Eldik,et al. Human amyloid β‐induced neuroinflammation is an early event in neurodegeneration , 2006 .
[84] Michela Matteoli,et al. Vesicular transmitter release from astrocytes , 2006, Glia.
[85] F. Gage,et al. Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation. , 2006, Stem cells and development.
[86] W. Griffin,et al. Inflammation and neurodegenerative diseases. , 2006, The American journal of clinical nutrition.
[87] L. V. Van Eldik,et al. Human amyloid beta-induced neuroinflammation is an early event in neurodegeneration. , 2006, Glia.
[88] J. Rothstein,et al. Mechanisms of Disease: astrocytes in neurodegenerative disease , 2006, Nature Clinical Practice Neurology.
[89] K. Fuxe,et al. Targeting adenosine A2A receptors in Parkinson's disease , 2006, Trends in Neurosciences.
[90] F. Eusebi,et al. Chemokine Fractalkine/CX3CL1 Negatively Modulates Active Glutamatergic Synapses in Rat Hippocampal Neurons , 2006, The Journal of Neuroscience.
[91] G. Burnstock,et al. Purinergic signalling in neuron–glia interactions , 2006, Nature Reviews Neuroscience.
[92] Michela Matteoli,et al. Synaptobrevin2‐expressing vesicles in rat astrocytes: insights into molecular characterization, dynamics and exocytosis , 2006, The Journal of physiology.
[93] A. Spada,et al. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport , 2006, Nature Neuroscience.
[94] Frank Kirchhoff,et al. Lack of the Kir4.1 channel subunit abolishes K+ buffering properties of astrocytes in the ventral respiratory group: impact on extracellular K+ regulation. , 2006, Journal of neurophysiology.
[95] A. Cuello,et al. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[96] D. Schubert,et al. Distribution of the Cystine/Glutamate Antiporter System x− c in the Brain, Kidney, and Duodenum , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[97] J. Lewerenz,et al. Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc– protects from oxidative glutamate toxicity , 2006, Journal of neurochemistry.
[98] Dong-Kug Choi,et al. Thalidomide and Lenalidomide Extend Survival in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis , 2006, The Journal of Neuroscience.
[99] Eberhard Fuchs,et al. Stress, depression and hippocampal apoptosis. , 2006, CNS & neurological disorders drug targets.
[100] G. Carmignoto,et al. Astrocyte control of synaptic transmission and neurovascular coupling. , 2006, Physiological reviews.
[101] A. Saavedra,et al. Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: Role of neuron–glia crosstalk , 2006, Neurobiology of Disease.
[102] S. Bauer,et al. The neuropoietic cytokine family in development, plasticity, disease and injury , 2007, Nature Reviews Neuroscience.
[103] J. Kordower,et al. Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? , 2007, Neurobiology of Disease.
[104] C. Cavaliere,et al. Gliosis alters expression and uptake of spinal glial amino acid transporters in a mouse neuropathic pain model. , 2007, Neuron glia biology.
[105] John D. Lambris,et al. The Classical Complement Cascade Mediates CNS Synapse Elimination , 2007, Cell.
[106] C. Cavaliere,et al. Reactive astrocytosis and glial glutamate transporter clustering are early changes in a spinocerebellar ataxia type 1 transgenic mouse model. , 2007, Neuron glia biology.
[107] D. Finn,et al. Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate , 2007, British journal of pharmacology.
[108] J. Platel,et al. GABA and glutamate signaling: homeostatic control of adult forebrain neurogenesis , 2007, Journal of Molecular Histology.
[109] A. Blöchl,et al. A cell‐biological model of p75NTR signaling , 2007, Journal of neurochemistry.
[110] M. Papa,et al. Opposing Control of Cannabinoid Receptor Stimulation on Amyloid-β-Induced Reactive Gliosis: In Vitro and in Vivo Evidence , 2007, Journal of Pharmacology and Experimental Therapeutics.
[111] K. McCarthy,et al. Conditional Knock-Out of Kir4.1 Leads to Glial Membrane Depolarization, Inhibition of Potassium and Glutamate Uptake, and Enhanced Short-Term Synaptic Potentiation , 2007, The Journal of Neuroscience.
[112] D. Cleveland,et al. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease , 2007, Nature Neuroscience.
[113] F. Kirchhoff,et al. Glutamate‐mediated neuronal–glial transmission , 2007, Journal of anatomy.
[114] S. Vannucci,et al. Supply and Demand in Cerebral Energy Metabolism: The Role of Nutrient Transporters , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[115] Dries Braeken,et al. Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity , 2007, Proceedings of the National Academy of Sciences.
[116] M. Robinson,et al. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention , 2007, Neurochemistry International.
[117] G. Zeevalk,et al. Glutathione and Parkinson's disease: is this the elephant in the room? , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[118] P. Brundin,et al. Emerging restorative treatments for Parkinson's disease , 2008, Progress in Neurobiology.
[119] M. Bergami,et al. Uptake and recycling of pro-BDNF for transmitter-induced secretion by cortical astrocytes , 2008, The Journal of cell biology.
[120] W. Friedman,et al. The function of p75NTR in glia , 2008, Trends in Neurosciences.
[121] J. Hung,et al. Astrocytic Ca2+ Waves Guide CNS Growth Cones to Remote Regions of Neuronal Activity , 2008, PloS one.
[122] R. Edwards,et al. Fast Subplasma Membrane Ca2+ Transients Control Exo-Endocytosis of Synaptic-Like Microvesicles in Astrocytes , 2008, The Journal of Neuroscience.
[123] K. Moore,et al. Induction of the Phase II Detoxification Pathway Suppresses Neuron Loss in Drosophila Models of Parkinson's Disease , 2008, The Journal of Neuroscience.
[124] L. Alberghina,et al. A New Nerve Growth Factor-Mimetic Peptide Active on Neuropathic Pain in Rats , 2008, The Journal of Neuroscience.
[125] J. Andersen,et al. MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology , 2008, PloS one.
[126] M. Gobbi,et al. Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. , 2008, European journal of pharmacology.
[127] Tomas C. Bellamy,et al. Interactions between Purkinje neurones and Bergmann glia , 2008, The Cerebellum.
[128] R. C. Reyes,et al. Mitochondria Modulate Ca2+-Dependent Glutamate Release from Rat Cortical Astrocytes , 2008, The Journal of Neuroscience.
[129] Martin Oheim,et al. Lysosomes Are the Major Vesicular Compartment Undergoing Ca2+-Regulated Exocytosis from Cortical Astrocytes , 2008, The Journal of Neuroscience.
[130] L. Lossi,et al. BDNF as a pain modulator , 2008, Progress in Neurobiology.
[131] Vladimir Parpura,et al. Ca2+ entry through TRPC1 channels contributes to intracellular Ca2+ dynamics and consequent glutamate release from rat astrocytes , 2008, Glia.
[132] B. Pettmann,et al. Signaling by death receptors in the nervous system , 2008, Current Opinion in Neurobiology.
[133] A. Vercelli,et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis , 2008, Neurobiology of Disease.
[134] K. Jacobsen,et al. A Nurr1 point mutant, implicated in Parkinson’s disease, uncouples ERK1/2-dependent regulation of tyrosine hydroxylase transcription , 2008, Neurobiology of Disease.
[135] H. Sontheimer,et al. Functional implications for Kir4.1 channels in glial biology: from K+ buffering to cell differentiation , 2008, Journal of neurochemistry.
[136] D. Sengelaub,et al. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse , 2008, Neuroscience.
[137] O. Lindvall,et al. Research in motion: the enigma of Parkinson's disease pathology spread , 2008, Nature Reviews Neuroscience.
[138] C. Cavaliere,et al. Neonatal separation stress reduces glial fibrillary acidic protein‐ and S100β‐immunoreactive astrocytes in the rat medial precentral cortex , 2009, Developmental neurobiology.
[139] J. Dostrovsky,et al. Astroglia in Medullary Dorsal Horn (Trigeminal Spinal Subnucleus Caudalis) Are Involved in Trigeminal Neuropathic Pain Mechanisms , 2009, The Journal of Neuroscience.
[140] G. Perea,et al. Tripartite synapses: astrocytes process and control synaptic information , 2009, Trends in Neurosciences.
[141] W. Friedman,et al. Inflammatory cytokines IL-1β and TNF-α regulate p75NTR expression in CNS neurons and astrocytes by distinct cell-type-specific signalling mechanisms , 2009, ASN neuro.
[142] L. Watkins,et al. Pathological and protective roles of glia in chronic pain , 2009, Nature Reviews Neuroscience.
[143] J. Nabekura,et al. Resting Microglia Directly Monitor the Functional State of Synapses In Vivo and Determine the Fate of Ischemic Terminals , 2009, The Journal of Neuroscience.
[144] Shin-ichi Muramatsu,et al. Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons , 2009, The Journal of Neuroscience.
[145] L. Alberghina,et al. Intrathecal NGF Administration Reduces Reactive Astrocytosis and Changes Neurotrophin Receptors Expression Pattern in a Rat Model of Neuropathic Pain , 2009, Cellular and Molecular Neurobiology.
[146] Daniel Choquet,et al. Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity , 2009, Nature Neuroscience.
[147] J. Hardy,et al. The genetics of Parkinson's syndromes: a critical review. , 2009, Current opinion in genetics & development.
[148] Grant R. Gordon,et al. Astrocyte-Mediated Distributed Plasticity at Hypothalamic Glutamate Synapses , 2009, Neuron.
[149] C. Gottfried,et al. Effects of atypical (risperidone) and typical (haloperidol) antipsychotic agents on astroglial functions , 2010, European Archives of Psychiatry and Clinical Neuroscience.
[150] U. Ziemann,et al. Interactions between short‐interval intracortical inhibition and short‐latency afferent inhibition in human motor cortex , 2009, The Journal of physiology.
[151] Chuan-en Wang,et al. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms , 2009, Proceedings of the National Academy of Sciences.
[152] Daniela Calvetti,et al. Astrocytes as the glucose shunt for glutamatergic neurons at high activity: an in silico study. , 2009, Journal of neurophysiology.
[153] R. Koehler,et al. Astrocytes and the regulation of cerebral blood flow , 2009, Trends in Neurosciences.
[154] C. Perrone-Capano,et al. Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology , 2009, Genes, brain, and behavior.
[155] J. Ojemann,et al. Uniquely Hominid Features of Adult Human Astrocytes , 2009, The Journal of Neuroscience.
[156] M. Smith,et al. Effects of memantine on soluble Αβ25-35-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions , 2009, Neuroscience.
[157] S. Moncada,et al. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C–Cdh1 , 2009, Nature Cell Biology.
[158] Jeffrey A. Johnson,et al. The Nrf2–ARE cytoprotective pathway in astrocytes , 2009, Expert Reviews in Molecular Medicine.
[159] F. Gage,et al. A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death , 2009, Cell.
[160] S. Subramony,et al. Bergmann Glial S100B Activates Myo-inositol Monophosphatase 1 and Co-localizes to Purkinje Cell Vacuoles in SCA1 Transgenic Mice , 2009, The Cerebellum.
[161] Alessandro Filosa,et al. Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport , 2009, Nature Neuroscience.
[162] S. Koizumi. Synchronization of Ca2+ oscillations: involvement of ATP release in astrocytes , 2010, The FEBS journal.
[163] R. Balice-Gordon,et al. Astrocyte secreted proteins selectively increase hippocampal GABAergic axon length, branching, and synaptogenesis , 2010, Molecular and Cellular Neuroscience.
[164] Understanding mental disorders from neuronal networks to glial cells and proteomics , 2010, European Archives of Psychiatry and Clinical Neuroscience.
[165] J. Julien,et al. Extracellular mutant SOD1 induces microglial‐mediated motoneuron injury , 2010, Glia.
[166] I. Yang,et al. Microglia and central nervous system immunity. , 2010, Neurosurgery clinics of North America.
[167] Alfredo Pereira,et al. Astrocytes and human cognition: Modeling information integration and modulation of neuronal activity , 2010, Progress in Neurobiology.
[168] Robert Zorec,et al. Gliotransmission: Exocytotic release from astrocytes , 2010, Brain Research Reviews.
[169] P. Maher,et al. Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target. , 2010, CNS & neurological disorders drug targets.
[170] E. Masliah,et al. Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies* , 2010, The Journal of Biological Chemistry.
[171] H. S. Kang,et al. Altered Cerebellar Development in Nuclear Receptor TAK1/TR4 Null Mice Is Associated with Deficits in GLAST+ Glia, Alterations in Social Behavior, Motor Learning, Startle Reactivity, and Microglia , 2010, The Cerebellum.
[172] M. Papa,et al. Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats , 2010, Neurochemistry International.
[173] D. R. Marsh,et al. Loss of GABAergic interneurons in laminae I-III of the spinal cord dorsal horn contributes to reduced GABAergic tone and neuropathic pain after spinal cord injury. , 2010, Journal of neurotrauma.
[174] Mikhail Inyushin,et al. Potassium channel activity and glutamate uptake are impaired in astrocytes of seizure‐susceptible DBA/2 mice , 2010, Epilepsia.
[175] S. Lehnardt,et al. Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injury , 2009, Glia.
[176] L. Monteggia. Toward neurotrophin-based therapeutics. , 2011, The American journal of psychiatry.
[177] A. Verkhratsky,et al. Astrocytes in Alzheimer’s disease , 2010, Neurotherapeutics.
[178] B. Mitterauer. Possible Role of Glia in Cognitive Impairment in Schizophrenia , 2011, CNS neuroscience & therapeutics.
[179] Y. Pankratov,et al. Distinct pharmacological and functional properties of NMDA receptors in mouse cortical astrocytes , 2011, British journal of pharmacology.
[180] F. Baas,et al. Innate and adaptive immunity in amyotrophic lateral sclerosis: Evidence of complement activation , 2011, Neurobiology of Disease.
[181] P. Fisher,et al. Role of Excitatory Amino Acid Transporter‐2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics , 2011, Journal of cellular physiology.
[182] M. Arpin,et al. Structural plasticity of perisynaptic astrocyte processes involves ezrin and metabotropic glutamate receptors , 2011, Proceedings of the National Academy of Sciences.
[183] L. Alberghina,et al. Reactive astrocytosis-induced perturbation of synaptic homeostasis is restored by nerve growth factor , 2011, Neurobiology of Disease.
[184] Francesco Vetri,et al. Purinergic mechanisms in gliovascular coupling. , 2011, Seminars in cell & developmental biology.
[185] K. Murai,et al. Eph receptors and ephrins in neuron–astrocyte communication at synapses , 2011, Glia.
[186] N. Hattori,et al. The effect of Ndrg2 expression on astroglial activation , 2011, Neurochemistry International.
[187] J. C. Baayen,et al. Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy , 2011, Epilepsia.
[188] S. Lovestone,et al. The impact of a novel apolipoprotein E and amyloid-β protein precursor-interacting protein on the production of amyloid-β. , 2011, Journal of Alzheimer's disease : JAD.
[189] M. Giustetto,et al. Synaptic Pruning by Microglia Is Necessary for Normal Brain Development , 2011, Science.
[190] M. Ciotti,et al. APP is Phosphorylated by TrkA and Regulates NGF/TrkA Signaling , 2011, The Journal of Neuroscience.
[191] Yue Zhu,et al. Signaling pathways of ATP‐induced PGE2 release in spinal cord astrocytes are EGFR transactivation‐dependent , 2011, Glia.
[192] P. Grant,et al. Reelin is a target of polyglutamine expanded ataxin-7 in human spinocerebellar ataxia type 7 (SCA7) astrocytes , 2012, Proceedings of the National Academy of Sciences.
[193] Randy F. Stout,et al. Glial cells in (patho)physiology , 2012, Journal of neurochemistry.
[194] Xin Wang,et al. Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. , 2012, Biochemical and biophysical research communications.
[195] P. Haydon,et al. Cocaine-related behaviors in mice with deficient gliotransmission , 2012, Psychopharmacology.
[196] C. Perrone-Capano,et al. Methylphenidate administration determines enduring changes in neuroglial network in rats , 2012, European Neuropsychopharmacology.
[197] Stephen J. Smith,et al. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors , 2012, Nature.
[198] M. Sofroniew,et al. Neurological diseases as primary gliopathies: a reassessment of neurocentrism , 2012, ASN neuro.
[199] K. Ozato,et al. IRF8 Is a Critical Transcription Factor for Transforming Microglia into a Reactive Phenotype , 2012, Cell reports.
[200] A. Kimura,et al. Chronic restraint stress decreases glial fibrillary acidic protein and glutamate transporter in the periaqueductal gray matter , 2012, Neuroscience.
[201] L. Alberghina,et al. Targeting reactive astrogliosis by novel biotechnological strategies. , 2012, Biotechnology advances.
[202] D. Holtzman,et al. Low-density Lipoprotein Receptor Represents an Apolipoprotein E-independent Pathway of Aβ Uptake and Degradation by Astrocytes* , 2012, The Journal of Biological Chemistry.
[203] Z. Cooper,et al. Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances , 2012, Expert opinion on investigational drugs.
[204] L. Alberghina,et al. BB14, a Nerve Growth Factor (NGF)-like peptide shown to be effective in reducing reactive astrogliosis and restoring synaptic homeostasis in a rat model of peripheral nerve injury. , 2012, Biotechnology advances.
[205] X. Tong,et al. Schizophrenia-Like Features in Transgenic Mice Overexpressing Human HO-1 in the Astrocytic Compartment , 2012, The Journal of Neuroscience.
[206] B. Barres,et al. Genomic Analysis of Reactive Astrogliosis , 2012, The Journal of Neuroscience.
[207] J. Littleton,et al. Mutation of a NCKX Eliminates Glial Microdomain Calcium Oscillations and Enhances Seizure Susceptibility , 2013, The Journal of Neuroscience.
[208] Xiaoliang Wang,et al. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models , 2013, Neuropharmacology.
[209] P. Mcgeer,et al. NOSH‐aspirin (NBS‐1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: A new candidate for treatment of neurodegenerative disorders , 2013, Glia.
[210] L. Alberghina,et al. Remodelling of supraspinal neuroglial network in neuropathic pain is featured by a reactive gliosis of the nociceptive amygdala , 2013, European journal of pain.
[211] N. J. Allen. Role of glia in developmental synapse formation , 2013, Current Opinion in Neurobiology.
[212] B. Vissel,et al. Microglia: A new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research , 2013, Neurobiology of Learning and Memory.
[213] P. C. Hopkins. Neurodegeneration in a Drosophila Model for the Function of TMCC2, an Amyloid Protein Precursor-Interacting and Apolipoprotein E-Binding Protein , 2013, PloS one.
[214] I. Campbell,et al. Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype , 2013, Glia.
[215] S. Lipton,et al. Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss , 2013, Proceedings of the National Academy of Sciences.
[216] Y. Chern,et al. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease. , 2013, Human molecular genetics.
[217] D. Offen,et al. Altered astrocytic response to activation in SOD1G93A mice and its implications on amyotrophic lateral sclerosis pathogenesis , 2013, Glia.
[218] Ben A. Barres,et al. Emerging roles of astrocytes in neural circuit development , 2013, Nature Reviews Neuroscience.